Voluntary Benefits

Disease-modifying antirheumatic drugs like Humira and Stelara now have more affordable competitors.

The non-U.S. supplier of a branded or patented drug could escape by starting to build a factory in the U.S.

Members of Congress want to know if the health market shift is a problem. The GAO says just measuring the shift is a problem.

For part-time workers, the health benefits access rate fell to 25% this year.

“The data show that costs associated with oncological care have increased over the past year, reflecting a trend of higher health care costs overall,” said Julie Stich, the group’s vice president of content at International Foundation of Employee Benefit Plans.

The federal No Surprises Act now requires health care providers and health insurers like Georgia Blue to take disputes over some out-of-network claims for insured patients to "independent dispute resolution" services rather than sending big bills to the patients.